RSV and COVID-19 Booster Study
Now Enrolling in Atlanta, Beaumont and Moore
Investigational Vaccine Study
Tekton Research is looking for adults (50+) to participate in an Investigational Respiratory Syncytial Virus (RSV) combined with an Investigational COVID-19 Booster Vaccine Study for older adults.
You may be eligible to take part if you:
- Are 50 years of age or older
- Are in good health
- Are fully vaccinated against COVID-19
- Have not tested positive for COVID-19 within the past 90 days
- Have not received any vaccine in the past month, or plan to receive a vaccine within a month after clinical trial vaccination
What is RSV?
RSV is a common respiratory virus that infects the lungs and breathing passages. People most often associate RSV with the risk it brings to young children, but not many know the high risk it poses for older adults. There are currently no approved treatments or vaccines for RSV.
Severe RSV infection is unpredictable and can be dangerous for certain adults, such as adults 50 years and older, those with chronic heart or lung disease, or those with a weakened immune system.
Why Tekton?
Tekton Research is a clinical research site that conducts clinical studies with the primary focus on improving the quality of life for all.
We work with pharmaceutical and device companies to help bring new and more effective medications to those who need them. We conduct studies with deliberate concentration on knowledge, skills and integrity.
Here at Tekton, our staff ensures that every potential and current study participant is accurately qualified for the most appropriate study based on criteria.
Interested In Signing Up?
"*" indicates required fields
